11:58 PM EDT, 08/20/2026 (MT Newswires) -- Fresenius SE (FRE.F) said Thursday it agreed to sell 7.8 million shares in Fresenius Medical Care (FME.F), representing 2.9% of the deconsolidated unit's issued share capital. The German healthcare company is selling the shares to institutional investors for 300 million euros. Net proceeds will be used for net debt reduction and future investments. The sale is expected to result in a low- to mid-double-digit-million-euro book gain in the group's third-quarter results.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.